BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/26/2026 6:06:22 AM | Browse: 3 | Download: 1
 |
Received |
|
2025-11-02 11:20 |
|
Peer-Review Started |
|
2025-11-02 11:20 |
|
First Decision by Editorial Office Director |
|
2025-11-05 07:47 |
|
Return for Revision |
|
2025-11-05 12:16 |
|
Revised |
|
2025-11-15 15:27 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-12-19 02:37 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-12-19 11:22 |
|
Articles in Press |
|
2025-12-19 11:22 |
|
Edit the Manuscript by Language Editor |
|
2025-12-22 03:33 |
|
Typeset the Manuscript |
|
2026-01-14 10:38 |
|
Publish the Manuscript Online |
|
2026-01-26 06:06 |
| ISSN |
1949-8470 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Radiotherapy combined with bevacizumab in gastrointestinal cancers: Balancing efficacy against the risk of intestinal perforation
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Yan Xu, Xiao-Bing Huang and Yong-Gang He |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Yong-Gang He, Associate Chief Physician, Department of Hepatobiliary, The Second Affiliated Hospital of Army Medical University, No. 83 Xinqiaozheng Street, Chongqing 400037, China. xqyyhyg@tmmu.edu.cn |
| Key Words |
Radiotherapy; Bevacizumab; Gastrointestinal cancers; Intestinal perforation; Combination therapy; Toxicity management |
| Core Tip |
The combination of radiotherapy and bevacizumab in gastrointestinal cancers offers enhanced efficacy but requires careful management due to an increased risk of intestinal perforation. Strategic patient selection and advanced radiotherapy techniques are essential to balance benefits and risks. |
| Publish Date |
2026-01-26 06:06 |
| Citation |
Xu Y, Huang XB, He YG. Radiotherapy combined with bevacizumab in gastrointestinal cancers: Balancing efficacy against the risk of intestinal perforation. World J Radiol 2026; 18(1): 116084 |
| URL |
https://www.wjgnet.com/1949-8470/full/v18/i1/116084.htm |
| DOI |
https://dx.doi.org/10.4329/wjr.v18.i1.116084 |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
